🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Status
Withdrawn
Location
Northwest Alabama Cancer Center
Start Date
2007-09
Trial ID
NCT00577161
Treatments Being Tested
This study is a multicentric trial evaluating the efficacy of the RFM regim...
Status
Completed
Location
Service de médecine D - Maladies du Sang CHU Angers
Start Date
2001-04
Trial ID
NCT00169208
Treatments Being Tested
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Status
Terminated
Location
University of Minnesota Masonic Cancer Center
Start Date
2020-09-07
Trial ID
NCT04551885
Treatments Being Tested
This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-10
Trial ID
NCT05182073
ATHENA chimeric antigen receptor (CAR)-T, a CD19-directed CAR-T cell immuno...
Status
Recruiting
Location
Biotherapeutic Department, Chinese PLA General Hospital
Start Date
2023-09-06
Trial ID
NCT06014073
This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Status
Recruiting
Location
District One Hospital
Start Date
2024-05-29
Trial ID
NCT06428188
Treatments Being Tested
Relapsed and refractory T-cell lymphomas have been reported to have dismal ...
Status
Recruiting
Location
Dong-A University
Start Date
2016-12
Trial ID
NCT02859402
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07153289
Treatments Being Tested
This is a single arm, open-label, non-randomized, dose-escalation, phase I ...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2020-01-15
Trial ID
NCT04232826
Treatments Being Tested